Concepedia

Stephane Navé

SN

10

Publications

502

Citations

10

H-Index

1997

Active since

Affiliations

Roche (Switzerland)(Current)

Roche (France)

Roche (United Kingdom)

Hôpitaux Universitaires de Strasbourg

AbbVie (United States)

Stephane Navé is an author at Roche (Switzerland) specializing in medicine, gynecologic surgery, and oxidative stress.

Top concepts

Publications per year

1997–2021

10

Publications

10

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy

Zhihua Li, Gary R. Mirams, Takashi Yoshinaga et al. · Clinical Pharmacology & Therapeutics · 2019 · 106 citations · Full text

Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate

A.M.W. Linssen, Eric Vuurman, Anke Sambeth et al. · Psychopharmacology · 2011 · 86 citations · Full text

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease

Edilio Borroni, Bernd Bohrmann, Fiona Grueninger et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 84 citations · Full text

, , +17

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

Stephane Navé, Rachelle S. Doody, Merçé Boada et al. · Journal of Alzheimer s Disease · 2017 · 46 citations · Full text

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

Joerg F. Hipp, Frédéric Knoflach, Robert A. Comley et al. · Scientific Reports · 2021 · 35 citations · Full text

Rows per page

1–5 of 10